Product Description
Introducing the New Nindanib 150mg Capsule, an outstanding advancement in anti-fibrotic therapy reserved for specialist care. Featuring soft gelatin capsules, this monumental prescription medicine is exquisitely formulated with Nintedanib 150mg for the gilt-edged management of Idiopathic Pulmonary Fibrosis (IPF). Each strip packs 10 capsules, with its box adorned in striking white and red graphics-a symbol of quality assurance from Glenmark Pharmaceuticals. Instant Checkout available for swift supply to exporters, manufacturers, and suppliers from India. Store at 25C for optimal efficacy. Prescription required for purchase.
Comprehensive Usage & Application Areas
Suitable for oral administration, Nindanib 150mg Capsule is typically prescribed for adult patients diagnosed with Idiopathic Pulmonary Fibrosis (IPF). The application medium is oral, utilizing innovative soft gelatin capsule technology for enhanced patient compliance. Ideal for use in specialized clinical settings, hospitals, and renowned pulmonary care centers, it supports anti-fibrotic treatment protocols under the guidance of a healthcare professional.
Certifications, Valuation & Premium Shipment Assurance
Nindanib 150mg Capsule upholds a premium pharmaceutical valuation, reflecting its certification and compliance standards overseen by Glenmark Pharmaceuticals. With outstanding delivery timelines, shipments are dispatched promptly following instant checkout for eligible buyers. Payment terms are designed to support both local and international clients, ensuring secure transactions and seamless order processing. Each pack is carefully inspected before shipment, underlining our commitment to quality and reliability.
FAQ's of Nindanib 150mg Capsule:
Q: How is Nindanib 150mg Capsule administered?
A: Nindanib 150mg Capsule is administered orally, typically under the supervision of a healthcare professional. It should be taken as prescribed by your physician, with or without food.
Q: What is the primary indication for Nindanib 150mg Capsule?
A: The primary indication for this medication is the treatment of Idiopathic Pulmonary Fibrosis (IPF), serving as an anti-fibrotic agent to help slow the progression of the disease.
Q: When should I consider using this product?
A: Nindanib 150mg Capsule should only be used following a prescription from a qualified doctor, usually upon diagnosis of IPF or as part of an established anti-fibrotic treatment regimen.
Q: Where is Nindanib 150mg sourced and marketed?
A: This product is manufactured and marketed by Glenmark Pharmaceuticals in India, making it accessible to both domestic and export markets.
Q: What are the key benefits of using Nindanib 150mg Capsule?
A: The main benefits include its soft gelatin formula for easy ingestion, its potent anti-fibrotic effect for IPF, and assurance of quality and authenticity as part of its premium packaging and certification process.
Send Inquiry
Send Inquiry
Send SMS
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese